BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 15481992)

  • 1. Structure modifications of 6-aminoquinolones with potent anti-HIV activity.
    Tabarrini O; Stevens M; Cecchetti V; Sabatini S; Dell'Uomo M; Manfroni G; Palumbo M; Pannecouque C; De Clercq E; Fravolini A
    J Med Chem; 2004 Oct; 47(22):5567-78. PubMed ID: 15481992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-dependent interference of a series of new 6-aminoquinolone derivatives with viral (HIV/CMV) transactivation.
    Stevens M; Balzarini J; Tabarrini O; Andrei G; Snoeck R; Cecchetti V; Fravolini A; De Clercq E; Pannecouque C
    J Antimicrob Chemother; 2005 Nov; 56(5):847-55. PubMed ID: 16150861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-AIDS agents. Part 61: Anti-HIV activity of new podophyllotoxin derivatives.
    Zhu XK; Guan J; Xiao Z; Cosentino LM; Lee KH
    Bioorg Med Chem; 2004 Aug; 12(15):4267-73. PubMed ID: 15246103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 1,8-naphthyridone derivative targets the HIV-1 Tat-mediated transcription and potently inhibits the HIV-1 replication.
    Massari S; Daelemans D; Barreca ML; Knezevich A; Sabatini S; Cecchetti V; Marcello A; Pannecouque C; Tabarrini O
    J Med Chem; 2010 Jan; 53(2):641-8. PubMed ID: 19958026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and anti-HIV activity of 4'-substituted 4'-thiothymidines: a new entry based on nucleophilic substitution of the 4'-acetoxy group.
    Haraguchi K; Shimada H; Tanaka H; Hamasaki T; Baba M; Gullen EA; Dutschman GE; Cheng YC
    J Med Chem; 2008 Mar; 51(6):1885-93. PubMed ID: 18311897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural investigation of the naphthyridone scaffold: identification of a 1,6-naphthyridone derivative with potent and selective anti-HIV activity.
    Tabarrini O; Massari S; Sancineto L; Daelemans D; Sabatini S; Manfroni G; Cecchetti V; Pannecouque C
    ChemMedChem; 2011 Jul; 6(7):1249-57. PubMed ID: 21567967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and biological evaluation of novel quinoline derivatives as HIV-1 Tat-TAR interaction inhibitors.
    Chen S; Chen R; He M; Pang R; Tan Z; Yang M
    Bioorg Med Chem; 2009 Mar; 17(5):1948-56. PubMed ID: 19217787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, anti-HIV-1 activity, and modeling studies of N-3 Boc TSAO compound.
    Tomassi C; Nguyen VN; Marco-Contelles J; Balzarini J; Pannecouque C; De Clercq E; Soriano E; Postel D
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2277-81. PubMed ID: 18353641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-AIDS agents. 34. Synthesis and structure-activity relationships of betulin derivatives as anti-HIV agents.
    Sun IC; Wang HK; Kashiwada Y; Shen JK; Cosentino LM; Chen CH; Yang LM; Lee KH
    J Med Chem; 1998 Nov; 41(23):4648-57. PubMed ID: 9804704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of 2-(2,6-dihalophenyl)-3-pyrimidinyl-1,3-thiazolidin-4-one analogues as anti-HIV-1 agents.
    Rawal RK; Tripathi R; Katti SB; Pannecouque C; De Clercq E
    Bioorg Med Chem; 2007 May; 15(9):3134-42. PubMed ID: 17349793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New anti-human immunodeficiency virus type 1 6-aminoquinolones: mechanism of action.
    Parolin C; Gatto B; Del Vecchio C; Pecere T; Tramontano E; Cecchetti V; Fravolini A; Masiero S; Palumbo M; Palù G
    Antimicrob Agents Chemother; 2003 Mar; 47(3):889-96. PubMed ID: 12604517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of human immunodeficiency virus type 1 replication and cytokine production by fluoroquinoline derivatives.
    Baba M; Okamoto M; Kawamura M; Makino M; Higashida T; Takashi T; Kimura Y; Ikeuchi T; Tetsuka T; Okamoto T
    Mol Pharmacol; 1998 Jun; 53(6):1097-103. PubMed ID: 9614214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationship study on anti-HIV 6-desfluoroquinolones.
    Tabarrini O; Massari S; Daelemans D; Stevens M; Manfroni G; Sabatini S; Balzarini J; Cecchetti V; Pannecouque C; Fravolini A
    J Med Chem; 2008 Sep; 51(17):5454-8. PubMed ID: 18710207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyanion inhibitors of HIV and other viruses. 7. Polyanionic compounds and polyzwitterionic compounds derived from cyclodextrins as inhibitors of HIV transmission.
    Leydet A; Moullet C; Roque JP; Witvrouw M; Pannecouque C; Andrei G; Snoeck R; Neyts J; Schols D; De Clercq E
    J Med Chem; 1998 Dec; 41(25):4927-32. PubMed ID: 9836609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and anti-HIV activity evaluation of novel 2,4-disubstituted 7-methyl-1,1,3-trioxo-2,4-dihydro-pyrazolo-[4,5-e][1,2]thiadiazines.
    Liu XY; Yan RZ; Wang Y; Zhan P; De Clercq E; Pannecouque C; Witvrouw M; Molina MT; Vega S
    Arch Pharm (Weinheim); 2008 Apr; 341(4):216-22. PubMed ID: 18266290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,2,3-Selenadiazole thioacetanilides: synthesis and anti-HIV activity evaluation.
    Zhan P; Liu X; Fang Z; Pannecouque C; De Clercq E
    Bioorg Med Chem; 2009 Sep; 17(17):6374-9. PubMed ID: 19647440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of 2-(2,6-dibromophenyl)-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV agents.
    Rawal RK; Tripathi R; Katti SB; Pannecouque C; De Clercq E
    Eur J Med Chem; 2008 Dec; 43(12):2800-6. PubMed ID: 18242784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-nucleoside HIV-1 reverse-transcriptase inhibitors. Part 10. Synthesis and anti-HIV activity of 5-alkyl-6-(1-naphthylmethyl)pyrimidin-4(3H)-ones with a mono- or disubstituted 2-amino function as novel 'dihydro-alkoxy-benzyl-oxopyrimidine' (DABO) analogues.
    Wang Y; Chen FE; Balzarini J; De Clercq E; Pannecouque C
    Chem Biodivers; 2008 Jan; 5(1):168-76. PubMed ID: 18205120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and anti-HIV-1 activity of new MKC-442 analogues with an alkynyl-substituted 6-benzyl group.
    Aly YL; Pedersen EB; La Colla P; Loddo R
    Arch Pharm (Weinheim); 2007 May; 340(5):225-35. PubMed ID: 17464964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and structure-activity relationships of phenylenebis(methylene)-linked bis-tetraazamacrocycles that inhibit human immunodeficiency virus replication. 2. Effect of heteroaromatic linkers on the activity of bicyclams.
    Bridger GJ; Skerlj RT; Padmanabhan S; Martellucci SA; Henson GW; Abrams MJ; Joao HC; Witvrouw M; De Vreese K; Pauwels R; De Clercq E
    J Med Chem; 1996 Jan; 39(1):109-19. PubMed ID: 8568797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.